Position in ALVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$333,860
+$64,787 QoQ
Shares Held
90,477
+15.3% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 72 holders
Holding Since
Mar 2023
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ALVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $1,945,758,306 across 45 Drug Manufacturers - Specialty & Generic names. ALVO ranks #37 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,523,018 | $396,884,069 | |
| 2 | VTRS |
Viatris Inc
|
20,771,275 | $329,847,840 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
473,109 | $256,344,645 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
1,077,317 | $181,571,000 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
5,306,326 | $130,588,679 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,430,011 | $116,208,767 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,842,983 | $75,617,590 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
1,882,499 | $68,146,461 |
All Filings in ALVO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $333,860 | 90,477 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $269,073 | 78,447 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $376,336 | 73,360 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $381,457 | 46,576 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $295,469 | 32,398 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $228,250 | 23,604 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $148,308 | 11,210 | Shares | Defined | 2025-02-13 | |
| 2023-03-31 | $1,887,915 | 146,350 | Shares | Defined | 2023-05-12 | |
| No filing history on record for this holder in this stock. | ||||||